{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Assessment+Questionnaires&page=11", "query": { "intervention": "Assessment Questionnaires", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 3756, "total_pages": 376, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Assessment+Questionnaires&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Assessment+Questionnaires&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T10:41:44.852Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05502055", "title": "Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+", "overall_status": "SUSPENDED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Sexual Orientation" ], "interventions": [ { "name": "Individual interviews", "type": "OTHER" }, { "name": "Focus Groups", "type": "OTHER" }, { "name": "National Survey", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Creighton University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 90, "start_date": "2022-10-18", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-11-06", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05502055" }, { "nct_id": "NCT04461184", "title": "The Great Plains Internet Wellness Study for Aging", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Internet Based Wellness Program", "Obesity", "Adult Population" ], "interventions": [ { "name": "Internet Wellness Intervention for Aging", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "North Dakota State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 14, "start_date": "2021-01-01", "completion_date": "2021-05-21", "has_results": false, "last_update_posted_date": "2021-05-25", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04461184" }, { "nct_id": "NCT04516135", "title": "Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Malignant Female Reproductive System Neoplasm" ], "interventions": [ { "name": "3-Dimensional Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Volume Modulated Arc Therapy", "type": "RADIATION" } ], "intervention_types": [ "RADIATION", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 28, "start_date": "2021-01-11", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 3, "location_summary": "Camden, New Jersey • Columbus, Ohio • Houston, Texas", "locations": [ { "city": "Camden", "state": "New Jersey" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04516135" }, { "nct_id": "NCT02166463", "title": "Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ann Arbor Stage IIB Hodgkin Lymphoma", "Ann Arbor Stage IIIB Hodgkin Lymphoma", "Ann Arbor Stage IVA Hodgkin Lymphoma", "Ann Arbor Stage IVB Hodgkin Lymphoma", "Childhood Hodgkin Lymphoma", "Classic Hodgkin Lymphoma" ], "interventions": [ { "name": "Bleomycin Sulfate", "type": "BIOLOGICAL" }, { "name": "Brentuximab Vedotin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "22 Years", "sex": "ALL", "summary": "2 Years to 22 Years" }, "enrollment_count": 600, "start_date": "2015-03-19", "completion_date": "2026-10-03", "has_results": true, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 182, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 140 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02166463" }, { "nct_id": "NCT02836093", "title": "Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Fatigue" ], "interventions": [ { "name": "FACIT-Fatigue 52-point questionnaire", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "18 Years to 80 Years · Female only" }, "enrollment_count": 45, "start_date": "2016-07-13", "completion_date": "2023-12-27", "has_results": false, "last_update_posted_date": "2023-12-29", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02836093" }, { "nct_id": "NCT05302817", "title": "Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Hyperpolarized xenon MRI", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Xemed LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 9, "start_date": "2023-03-17", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2026-01-20", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05302817" }, { "nct_id": "NCT02843217", "title": "Regional Native American Community Networks Program (RNACNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Lifestyle, screening", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 1458, "start_date": "2010-09", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1, "location_summary": "Pullman, Washington", "locations": [ { "city": "Pullman", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02843217" }, { "nct_id": "NCT03233555", "title": "Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stage I Breast Cancer", "Stage I Colorectal Cancer AJCC v6 and v7", "Stage I Prostate Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer", "Stage II Colorectal Cancer AJCC v7", "Stage II Prostate Cancer", "Stage IIA Breast Cancer", "Stage IIA Colorectal Cancer AJCC v7", "Stage IIA Prostate Cancer", "Stage IIB Breast Cancer", "Stage IIB Colorectal Cancer AJCC v7", "Stage IIB Prostate Cancer", "Stage IIC Colorectal Cancer AJCC v7", "Stage III Colorectal Cancer AJCC v7", "Stage IIIA Colorectal Cancer AJCC v7", "Stage IIIB Colorectal Cancer AJCC v7", "Stage IIIC Colorectal Cancer AJCC v7" ], "interventions": [ { "name": "Informational Intervention", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Telephone-Based Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 535, "start_date": "2013-09-03", "completion_date": "2022-07-31", "has_results": false, "last_update_posted_date": "2022-08-29", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 2, "location_summary": "New Brunswick, New Jersey • Philadelphia, Pennsylvania", "locations": [ { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03233555" }, { "nct_id": "NCT03023215", "title": "Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meditation for Breast Biopsy" ], "interventions": [ { "name": "Meditation", "type": "PROCEDURE" }, { "name": "Electroencephalogram", "type": "PROCEDURE" }, { "name": "Questionnaires", "type": "BEHAVIORAL" }, { "name": "Heart Rate", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 84, "start_date": "2012-10-26", "completion_date": "2022-08-10", "has_results": false, "last_update_posted_date": "2023-09-07", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03023215" }, { "nct_id": "NCT04457596", "title": "T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "HER2 Positive Breast Carcinoma", "Invasive Breast Carcinoma", "Multifocal Breast Carcinoma", "Synchronous Bilateral Breast Carcinoma", "Anatomic Stage I Breast Cancer AJCC v8" ], "interventions": [ { "name": "Trastuzumab Emtansine", "type": "BIOLOGICAL" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Tucatinib", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1056, "start_date": "2021-03-02", "completion_date": "2035-05-31", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-23T10:41:44.852Z", "location_count": 1160, "location_summary": "Birmingham, Alabama • Fairhope, Alabama • Mobile, Alabama + 749 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04457596" } ] }